A. Taliento

Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease

D. Prati, A. Federico, M. Dallio, 2019, International journal of environmental research and public health.

Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic “Stromal” Cells from Giant Cell Tumors of Bone

H. Gelderblom, P. Hogendoorn, M. A. van de Sande, 2022, Cancers.

Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker

D. Prati, G. Baselli, A. Fracanzani, 2020, Gut.

PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings

C. Byrne, D. Prati, C. Maffeis, 2020, Liver international : official journal of the International Association for the Study of the Liver.

A polygenic risk score for progressive non-alcoholic fatty liver disease risk stratification

L. N. Valenti, H. Reeves, D. Prati, 2020 .